Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
HCC not related to HBV, HCV increases over time
The fibrosis-4 index may be a useful screening method for hepatocellular carcinoma among patients with non-hepatitis B and non-hepatitis C virus, according to research published in BMC Gastroenterology.
Peer support positively impacts HCV treatment, outcomes
Peer support within marginalized groups at risk for hepatitis C virus increased treatment initiation and completion as well as improved outcomes, according to a presenter at The International Liver Congress.
Log in or Sign up for Free to view tailored content for your specialty!
Routine bloodborne virus testing integrates feasibly, effectively, sustainably in UK EDs
Routine testing for bloodborne viruses in EDs proved easily integrated and cost-effective in the U.K., according to a presentation at The International Liver Congress.
Liver cancer test algorithm identifies risk for HCC in hepatitis C
Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at low risk for hepatocellular carcinoma, according to a study presented at The Digital International Liver Congress.
Generic DAA therapy safely, effectively treats pediatric HCV
Administration of direct-acting antiviral agents safely and effectively treated children with hepatitis C, according to a presentation at the International Liver Congress.
Liver function test identifies difficult to diagnose patients with HCV
Intelligent liver function testing successfully identified patients with hepatitis C who were previously undiagnosed, many of whom did not fit traditional at-risk profiles, according to a presentation at the International Liver Conference.
Researchers call for immediate treatment without restriction in hepatitis C
Researchers called for immediate treatment action without restriction among patients with hepatitis C for continued progress in virus elimination following COVID-19, according to a presentation at The Digital International Liver Congress.
Researchers find changes in ultrasound quality for HCC screening
Ultrasound quality changed between examinations for hepatocellular carcinoma detection in patients with cirrhosis, according to research published in Clinical Gastroenterology and Hepatology.
FDA says children aged as young as 3 years can take Epclusa for hepatitis C
Under an FDA-approved expansion of the pediatric indication, children as young as age 3 years are now able to receive Epclusa for the treatment of chronic hepatitis C virus regardless of HCV genotype or severity.
Combination ravidasvir, sofosbuvir effectively treats chronic hepatitis C
Ravidasvir in addition to sofosbuvir was safe and effective in the treatment of patients with chronic hepatitis C virus, according to research published in The Lancet Gastroenterology and Hepatology.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read